Navigation Links
Chemoradiation in Medical News

Is Radiation or Chemoradiation Best for Oropharyngeal Cancer Patients

Patients with stage IV oropharyngeal cancer -- a type of cancer that develops in the part of the throat just behind the mouth// that assists with breathing, talking, eating, chewing, and swallowing -- are often treated with radiation alone or with chemoradiation. The addition of chemotherapy is usu...

Advanced targeted therapies effective as first-line treatment for lung cancer

...l 3. EFFICIENCY OF MAINTENANCE ERLOTINIB VERSUS PLACEBO IN PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL LUNG CANCER (NSCLC) FOLLOWING CONCURRENT chemoradiation (D0410, NCT00153803) (ABSTRACT # C6.1) Currently, the role of maintenance therapy following concurrent treatment with chemotherapy and radiotherap...

NCCN Announces Updates to Pancreatic Adenocarcinoma Guidelines

...able disease. Dr. Tempero also provided additional clarification regarding the importance of upfront systemic therapy prior to administration of chemoradiation therapy stating that, "Radiation is important for a subset of patients with local disease only, but systemic chemotherapy should be given first." ...

MRI and PET/CT improve cervical cancer patient's chances for optimal treatment

...ely, spare them surgery and have them treated with chemoradiation alone," she said. Study results showed that while... if they were simply treated with surgery alone or chemoradiation alone. Our study shows how pre-treatment imaging m... improve chances of correctly receiving surgery or chemoradiation instead of both," said Dr. Pandharipande. "M...

CAPHOSOL results in minimal oral mucositis and pain in head/neck cancer patients

...aily for 76% of the days. Only four patients (7 percent) interrupted their chemoradiation regimen due to OM; none of these interruptions lasted longer than seven day...owing body of evidence supporting the use of CAPHOSOL from the beginning of chemoradiation therapy, as this rinse decreases the incidence and severity of oral mucosit...

Jefferson doctor receives Tree of Life award

...hell's research in pancreatic cancer and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria and supportive care for patients with gastrointestinal cancer. She travels natio...

How to treat gastroesophageal adenocarcinom patients?

...atients diagnosed between 1996 and 1999 found that chemoradiation without surgery was most frequent therapy, although patients given chemoradiation followed by surgery had better survival compared to chemoradiation alone. Research suggests community-based use of tr...

HPV Tied to Better Tongue, Tonsil Cancer Outcomes

...idence of cancer, and 73 percent fully preserved their organs. Of the 11 patients referred for surgery, only four survived. "For most patients, the chemoradiation was very effective. But a subset of patients still do not do well. Our next step was to look at the biomarkers to see if we could determine which pati...

HPV linked to better survival in tonsil, tongue cancer, U-M study finds

...rapy and radiation went on to receive surgery. The researchers found that even with surgery, only 4 of 11 patients survived. For most patients, the chemoradiation was very effective. But a subset of patients still do not do well. Our next step was to look at the biomarkers to see if we could determine which pati...

Study finds cisplatin less effective than standard treatment for patients with anal cancer

...egy for treating the disease because previous studies have established that chemoradiation is more effective for smaller anal canal carcinomas than larger ones. "...nd colostomy-free survival relative to the continued standard of concurrent chemoradiation with fluorouracil and mitomycin. ...
Chemoradiation in Medical Technology

CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation

New Data Underscore the Utility of CAPHOSOL in Treating Oral Mucositis PRINCETON, N.J., May 21 /PRNewswire/ -- New data show that CAPHOSOL(R) (http://www.caphosol.com ), an advanced electrolyte solution, relieves painful oral mucositis (OM) and improves quality of life for cancer patients un...

TNFerade(TM) Phase III Data Presented at ASCO

...in/prnh/20081205/DC50112LOGO ) The poster , entitled "Multi-Center Randomized Controlled Phase III Clinical Trial using TNFerade(TM) with chemoradiation in Patients with Locally Advanced Pancreatic Cancer: Interim Analysis of Overall Survival," reported on results of an interim analysis from the PACT t...

Study Showed Lilly's GEMZAR(R) (gemcitabine HCl for injection) Improved Progression-Free Survival in Cervical Cancer Patients

...sion-free survival at three years for patients treated with the gemcitabine chemoradiation combination versus those treated only with chemoradiation (74% vs. 65%, respectively). Patients on the gemcitabine arm experienced s...

BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting

...co.org , reports that OncoVEX GM-CSF was well tolerated, with no significant additional side effects noted over and above those which are common with chemoradiation alone. With respect to efficacy, 94% of patients had a complete pathological response noted at surgery, with five patients achieving a complete respon...

YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

...ewing session. The poster presentation, Multi-Center, Phase 2/3, Randomized, Controlled Clinical Trial using TNFerade(TM) Gene Delivery Combined with chemoradiation in Patients with Locally Advanced Pancreatic Cancer (LAPC), covered the most recent data from GenVec's Pancreatic Cancer Clinical Trial, known as the ...
Chemoradiation in Biological News

CAPHOSOL relieves oral mucositis and improves quality-of-life in cancer patients

...lyte Oral Rinse Aids Quality of Life for Head/Neck chemoradiation Patients" (Haas, ML), was selected by an ONS Exper...Neck Cancer Oral mucositis occurs in nearly all chemoradiation patients with HNC. Dr. Haas will present a subset...lyte Oral Rinse Aids Quality of Life for Head/Neck chemoradiation Patients. These data confirm high levels of pati...
Chemoradiation in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

...merican Society for Clinical Oncology. The poster , entitled "Multi-Center Randomized Controlled Phase III Clinical Trial using TNFerade(TM) with chemoradiation in Patients with Locally Advanced Pancreatic Cancer: Interim Analysis of Overall Survival," reported on results of an interim analysis from the PACT t...

YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB

...y at the 2009 ASCO Annual Meeting from a randomized Phase IIb, four-arm, open-label trial of nimotuzumab in combination with radiation therapy (RT) or chemoradiation therapy (CRT) in patients with inoperable, locoregionally advanced Stage III/IVa head and neck cancer conducted in India by Reddy BK et al. The additi...

NIMOTUZUMAB DEMONSTRATES EFFICACY IN RANDOMIZED HEAD & NECK CANCER STUDY WITHOUT THE TOXICITIES ASSOCIATED WITH OTHER EGFR DRUGS

...umab in combination with radiation therapy (RT) or chemoradiation therapy (CRT) in patients with inoperable (Stage I... addition of nimotuzumab to both the radiation and chemoradiation regimens improved the overall response rate, survi...noclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with adva...

YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING

...entitled "A phase IIb 4-arm open-label randomized study to assess the safety and efficacy of h-R3 monoclonal antibody against EGFR in combination with chemoradiation therapy or radiation therapy in patients with advanced (stage III or IVA) inoperable head and neck cancer (abstract # 6041)" will be presented in the ...

YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

...model, towards approval and commercialization worldwide. Nimotuzumab is in development targeting multiple tumor types in combination with radiation, chemoradiation and chemotherapy. The humanized monoclonal antibody, which is approved for marketing in twelve of countries, is significantly differentiated from all ...

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...

YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE

...y composition of free and liposome-encapsulated fentanyl. Nimotuzumab is in development targeting multiple tumour types in combination with radiation, chemoradiation and chemotherapy. The drug, which is approved for marketing in a number of countries, is significantly differentiated from all other currently markete...
Other Tags
(Date:11/21/2014)... London, UK (PRWEB) November 21, 2014 ... only ISO verified healthcare professional panel, today announced two important ... appointment of Roni DasGupta as President of Market Research, Americas ... Market Research, Europe. , Ms. DasGupta joined M3 ... President and most recently Head of Sales. Roni has ...
(Date:11/21/2014)... Dennis Thompson HealthDay Reporter ... or obese women who get pregnant are much more likely ... an adult, new research suggests. But it looks like ... trend, the researchers added. "Mothers who are overweight teach ... Dr. Michael Mendelson. He is a research fellow at the ...
(Date:11/21/2014)... THURSDAY, Nov. 20, 2014 (HealthDay News) -- Some people ... the implant,s internal magnet when they undergo an MRI ... information supplied by the researchers, about 300,000 people worldwide ... sound to people who are deaf or have severe ... among people with cochlear implants when undergoing MRI. ...
(Date:11/21/2014)... Gordon HealthDay Reporter THURSDAY, ... agencies have proposed new rules that will make it easier ... or not. The proposed changes would expand the ... their results to ClinicalTrials.gov -- a publicly accessible database, according ... U.S. Department of Health and Human Services. "This ...
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- Kidney donation is ... for another. And now a new study finds that former ... are benefiting from policies that give them priority on the ... 6,300 of the 16,900 kidney transplants that took place in ... by the study researchers. At the time of ...
Breaking Medicine News(10 mins):Health News:M3 Global Research Announces Leadership Team Promotions in US and EU 2Health News:Kids Born to Overweight Moms May Face Higher Heart Risks as Adults 2Health News:MRI Can Be Painful, Disruptive for People With Cochlear Implants 2Health News:U.S. Proposes Greater Public Access to Data From Clinical Trials 2Health News:Study Supports Giving Kidney Donors Priority When They Need a Kidney 2
(Date:11/7/2014)... SPRINGS, Florida , November 6, 2014 ... secure authentication for better mobile security revolutionizing online transactions.  Companies ... ), Alibaba Holdings Ltd. (NYSE: BABA ), Google ... MSFT ), eBay Inc. (NASDAQ: EBAY ) ... NXTD and NXTDW), a biometric authentication company ...
(Date:11/6/2014)... 2014 - Insilico Medicine, Inc, a Baltimore-based bioinformatics ... related diseases announced a research collaboration with the ... Oncology, Inc (OTC: CSBR). , "There are many ... but Champions Oncology,s TumorGraft technology is unique in ... regimen experimentally generating vast amounts of valuable data. ...
(Date:11/4/2014)... of Utah engineers developed the first room-temperature fuel cell ... without needing to ignite the fuel. These new fuel ... power and sensors. , A study of the new ... journal ACS Catalysis . , Fuel cells convert ... fuel and an oxygen-rich source such as air. If ...
Breaking Biology News(10 mins):Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 2Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 3Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 4Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 5Universal Authentication Methods Provide More Secure Operations for Biometrics Devices - Company Joins FIDO Alliance for Consumer Protection 6Insilico Medicine, Inc announces research collaboration with Champions Oncology, Inc 2Jet-fueled electricity at room temperature 2
Other Contents